Trials / Conditions / Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor

Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor

4 registered clinical trials studyying Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Clinical Study of the Combination of Anlotinib and Aumolertinib in the First-line Treatment of Advanced NSCL NCT06102928	Kunming Medical University	N/A
Recruiting	LAT for Oligoprogressive NSCLC Treated With First-line OSImertinib NCT04216121	Universitaire Ziekenhuizen KU Leuven	—
Active Not Recruiting	HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small NCT04619004	Daiichi Sankyo	Phase 2
Unknown	Stereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung Cancer NCT06207292	Radiotherapy Oncology Centre "Santa Maria" Hospital	N/A